212 related articles for article (PubMed ID: 1520594)
1. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma.
Starzynska T; Bromley M; Ghosh A; Stern PL
Br J Cancer; 1992 Sep; 66(3):558-62. PubMed ID: 1520594
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma.
Joypaul BV; Hopwood D; Newman EL; Qureshi S; Grant A; Ogston SA; Lane DP; Cuschieri A
Br J Cancer; 1994 May; 69(5):943-6. PubMed ID: 8180028
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of p53 in gastric carcinoma.
Fukunaga M; Monden T; Nakanishi H; Ohue M; Fukuda K; Tomita N; Shimano T; Mori T
Am J Clin Pathol; 1994 Feb; 101(2):177-80. PubMed ID: 8116572
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma.
Kawasaki Y; Monden T; Morimoto H; Murotani M; Miyoshi Y; Kobayashi T; Shimano T; Mori T
Am J Clin Pathol; 1992 Feb; 97(2):244-9. PubMed ID: 1546693
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.
Tollenaar RA; van Krieken JH; van Slooten HJ; Bruinvels DJ; Nelemans KM; van den Broek LJ; Hermans J; van Dierendonck JH
Br J Cancer; 1998 Jun; 77(11):1842-7. PubMed ID: 9667656
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
Zhang Hong
Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.
Jang WI; Yang WI; Lee CI; Kim HS; Song KS; Cho MY; Park JK; Shim YH
J Korean Med Sci; 1993 Aug; 8(4):293-304. PubMed ID: 7911025
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of p53 overexpression in formalin-fixed, paraffin-embedded sections of endometrial carcinoma.
Iwai K; Hachisuga T; Iwasaka T; Sugimori H
J Obstet Gynaecol (Tokyo 1995); 1995 Dec; 21(6):593-600. PubMed ID: 8640471
[TBL] [Abstract][Full Text] [Related]
9. p53 expression and prognosis in gastric carcinoma.
Martin HM; Filipe MI; Morris RW; Lane DP; Silvestre F
Int J Cancer; 1992 Apr; 50(6):859-62. PubMed ID: 1555884
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of p53 accumulation in gastric carcinoma.
Starzynska T; Markiewski M; Domagala W; Marlicz K; Mietkiewski J; Roberts SA; Stern PL
Cancer; 1996 May; 77(10):2005-12. PubMed ID: 8640663
[TBL] [Abstract][Full Text] [Related]
11. Study of P53 protein expression in colorectal cancer.
Sulkowska M; Famulski W; Guzińska-Ustymowicz K; Sulkowski S
Folia Histochem Cytobiol; 2001; 39(2):157-8. PubMed ID: 11374803
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
[TBL] [Abstract][Full Text] [Related]
13. [Effect of overexpression of P53 protein in colorectal carcinoma on short-term prognosis].
Domínguez Iglesias F; Riera Velasco JR; Junco Petrement P; Tojo Ramallo P; Díaz-Faes Cervero M
Rev Esp Enferm Dig; 1994 Nov; 86(5):796-802. PubMed ID: 7848689
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of p53 protein in the different histological subtypes of gastric carcinoma.
Teh M; Lee YS
Pathology; 1994 Oct; 26(4):432-4. PubMed ID: 7892045
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 protein in gastric carcinomas is not independently prognostic.
Motojima K; Furui J; Kohara N; Ito T; Kanematsu T
Surgery; 1994 Nov; 116(5):890-5. PubMed ID: 7940194
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage II colorectal cancer.
Clarke G; Ryan E; Crowe J; O'Keane JC; MacMathúna P
Eur J Histochem; 1999; 43(4):311-6. PubMed ID: 10682269
[TBL] [Abstract][Full Text] [Related]
17. p53 protein immunostaining in routinely processed paraffin-embedded sections.
Bruner JM; Connelly JH; Saya H
Mod Pathol; 1993 Mar; 6(2):189-94. PubMed ID: 8483890
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma--a multivariate analysis of prognostic factors.
Kim JP; Oh ST; Hwang TS; Chi JG
J Korean Med Sci; 1994 Jun; 9(3):248-53. PubMed ID: 7993593
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of p53 in relation to long-term prognosis in colorectal carcinoma.
Starzynska T; Bromley M; Marlicz K; Roberts SA; Ucinski M; Stern PL
Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):183-6. PubMed ID: 9058631
[TBL] [Abstract][Full Text] [Related]
20. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
